Endo Pharmaceuticals Holdings Inc--Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): November 8, 2005 (November 8, 2005)

 


 

Endo Pharmaceuticals Holdings Inc.

(Exact name of registrant as specified in its charter)

 


 

Delaware   001-15989   13-4022871

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

 

100 Endo Boulevard, Chadds Ford, PA   19317
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (610) 558-9800

 

Not Applicable

Former name or former address, if changed since last report

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


Item 7.01. Regulation FD Disclosure.

 

On November 9, 2005, the Registrant intends to make a slide presentation at the SG Cowen Global Health Care Conference in Barcelona, Spain, a copy of which presentation is filed herewith as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(a) Financial Statements of Business Acquired.

 

Not applicable.

 

(b) Pro Forma Financial Information.

 

Not applicable.

 

(c) Exhibits.

 

Exhibit
Number


 

Description


99.1   Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated November 9, 2005

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

ENDO PHARMACEUTICALS HOLDINGS INC.
(Registrant)

By:

 

/s/ CAROLINE B. MANOGUE


Name:

  Caroline B. Manogue

Title:

 

Executive Vice President, Chief

Legal Officer & Secretary

 

Dated: November 8, 2005

INDEX TO EXHIBITS

 

Exhibit No.

 

Description    


99.1   Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated November 9, 2005